Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177918 · ClinicalTrials.gov registry record
Prospective Evaluations of Infectious Complication in Lung Transplant Recipients
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 600
- Enrollment target
NCT00177918: Completed study, sponsored by University of Pittsburgh.
NCT00177918 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00177918 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
The primary aim of this study is to determine prospectively the viral and C. pneumoniae infection prevalence and outcomes of infections in lung transplant recipients. The study will also determine the correlation of C. pneumoniae infection with the development of obliterans in lung transplant recipients.
Primary Outcome
looking at death rate five years post lung transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2006-08 |
| Est. Completion | 2026-01-01 |
What the finished NCT00177918 record still lists
NCT00177918 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00177918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00177918 about?
NCT00177918 is a clinical study titled "Prospective Evaluations of Infectious Complication in Lung Transplant Recipients". The primary aim of this study is to determine prospectively the viral and C. pneumoniae infection prevalence and outcomes of infections in lung transplant recipients. The study will also determine the correlation of C. pneumoniae infection with the development of obliterans in lung transplant recipi...
What is the current status of trial NCT00177918?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2006-08. Estimated completion is 2026-01-01.
Who is sponsoring clinical trial NCT00177918?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia